Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin

Mise à jour : Il y a 4 ans
Référence : NCT00362934

Femme et Homme

Extrait

Mixed or combined hyperlipidemia is a common metabolic disorder characterized by both hypercholesterolemia and hypertriglyceridemia. Statins and fibrates have complementary mechanisms and can be coadministered to patients with mixed hyperlipidemia. The overall objective of the study is to compare the efficacy and safety of combining fenofibrate and simvastatin versus atorvastatin monotherapy in patients with mixed hyperlipidemia at risk of cardiovascular diseases.


Critère d'inclusion

  • Hyperlipidemia


Liens